Decreased gap junctional intercellular communication in hexachlorobenzene-induced gender-specific hepatic tumor formation in the rat.
Hexachlorobenzene (HCB), an epigenetic carcinogen, HCB induces the formation of liver tumors in female rats, whereas only a small percentage of males are responsive. Intercellular communication via gap junctions is decreased in carcinogenesis. Gap junctions are composed of proteins termed connexins (Cxs). The objectives of this study were (i) to determine if HCB-induced tumor development is associated with a loss of gap junctional communication; (ii) to assess if HCB causes a gender-specific decrease in the expression of Cx32 and Cx26; and (iii) to establish if these effects result from gender differences in the constitutive expression of these Cxs. Rats were given HCB by gavage for five consecutive days. In the first experiment, control and HCB-treated female rats were sampled on day 100. Intercellular communication was significantly decreased in HCB-treated females compared to controls. To investigate if changes in Cx levels occur prior to day 100, experiments done using male and female rats sampled on day 50. Hepatic mRNA levels for Cx26 and Cx32 were significantly lower only in HCB-treated females as compared to controls. Cx26 mRNA levels were 3-fold higher and Cx32 mRNA levels were 8-fold lower in females compared with males. In a third experiment, ovariectomy abolished any differences between male and female controls for both Cxs, while estradiol had a partial role in the regulation of Cx32. This suggests that the sexual dimorphism in hepatic Cx levels is determined by the ovarian hormones. However, the HCB-induced decrease in Cx32 and Cx26 mRNA levels was maintained in ovariectomized rats, suggesting that the HCB effects are not mediated via an ovary-dependent pathway. Overall results show that HCB exposure induces gender-specific long-term alterations in intercellular gap junctional communication in female rat liver. This effect appears to be a critical mechanism of HCB-induced liver carcinogenesis and tumor promotion.
Human Health Research Center, INRS-Institut Armand-Frappier, 245 Hymus Boulevard, Université du Québec, Pointe-Claire, Quebec H9R 1G6, Canada.
Isabelle
I
Plante
Michel
M
Charbonneau
Daniel G
DG
Cyr
D000818:Animals; D015152:Blotting, Northern; D015153:Blotting, Western; D002450:Cell Communication / Q000502:physiology*; D000072259:Connexin 26; D017630:Connexins / Q000235:genetics / Q000378:metabolism*; D015536:Down-Regulation; D005260:Female; D005659:Fungicides, Industrial / Q000633:toxicity*; D017629:Gap Junctions / Q000502:physiology*; D006581:Hexachlorobenzene / Q000633:toxicity*; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D008297:Male; D010052:Ovariectomy; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012737:Sex Factors; D014407:Tumor Cells, Cultured; D000097002:Gap Junction beta-1 Protein
D000072259:Connexin 26; D017630:Connexins; D005659:Fungicides, Industrial; D006581:Hexachlorobenzene; D012333:RNA, Messenger; D000097002:Gap Junction beta-1 Protein; C000607042:GJB2 protein, human; C000607044:Gjb2 protein, rat